INTRODUCTION
============

*Enterococcus* spp. are opportunistic pathogens that inhabit the intestines of many warm-blooded animals, including humans, and have been isolated from several sources such as food, plants, water, and soil \[[@B1]\]. *Enterococcus* spp. can infect birds through various routes including the respiratory system, gastrointestinal tract, and integument, particularly in poultry environments where birds are hatched, reared, or processed. After infection, bacteria circulate in the bloodstream and form abscesses that cause arthritis, osteomyelitis, spondylitis, and femoral head necrosis in broiler and broiler breeder flocks \[[@B2]-[@B4]\]. Virulence of *Enterococcus* spp. is associated with several genes including *fsr* (regulator of *gelE* expression), *efm* (*E. faecium*-specific cell wall adhesin), *esp* (enterococcal surface protein), *cylA* (hemolysin), *cad1* (pheromone cAD1 precursor lipoprotein), *ace* (collagen-binding cell wall protein), *gelE* (gelatinase), *asa1* (aggregation substance), *acm* (surface-exposed antigen), *cpd1* (pheromone cPD1 lipoprotein), *efaAEfs* (endocarditis-specific antigen), and *sagA* (secreted antigen) \[[@B5],[@B6]\]. These virulence factors are involved in attachment to target organs, colonization, invasion of host tissues, diminished host immune function, and the production of enzymes that increase the severity of infection and regulate extracellular production of toxins \[[@B7]-[@B9]\].

The use of antimicrobials to enhance the production of animals for human consumption of meat and eggs is leading to increased antimicrobial resistance worldwide. *Enterococcus* spp. acquire antibiotic resistance via transfer of plasmids and transposons, chromosomal exchange, and spontaneous mutations \[[@B6]\]. Consequently, the use of antibiotics for animal growth promotion exposes humans to antibiotic-resistant pathogens through food and contaminates the environment, which facilitates spreading.

Herein, we developed a multiplex polymerase chain reaction (PCR) method for simultaneous detection of 8 virulence genes in *Enterococcus* spp. and investigated potential virulence factors and antimicrobial resistance using *E. faecium*, *E. faecalis*, *E. hirae*, and *E. gallinarum* isolates from broiler chickens suffering lameness in 2 commercial poultry farms.

MATERIALS AND METHODS
=====================

Isolation of bacteria
---------------------

*Enterococcus* spp. were isolated from various samples of 13 different flocks suffering from lameness in 2 commercial poultry farms over a period of 7 weeks in 2016. Broilers with lameness varied in age from 2 to 15 days. Swabs from liver, femur, and joint tissue were inoculated onto Enterococcosel agar and blood agar plates (BD Diagnostics, Germany) and cultivated at 37°C for 18--24 h. After the initial growth period, dark brown colonies on selective Enterococcosel agar medium were presumptively characterized as *Enterococcus* spp. and subcultured in brain heart infusion (BHI) agar for *Enterococcus* species-specific identification using 16s rRNA sequencing analysis and conventional biochemical testing, including Gram staining and Vitek2.

DNA extraction
--------------

Total genomic DNA was isolated from 80 different bacterial species using a QIAamp DNA mini kit (Qiagen, Germany) according to the manufacturer\'s instructions.

Oligonucleotide primer design
-----------------------------

Specific primers were designed based on published *fsr* (GenBank accession No. JN246675), *efm* (GenBank accession No. AF097414), *esp* (GenBank accession No. AH013271 and JF826520), *cylA* (GenBank accession No. JQ794947 and KY613925), *cad1* (GenBank accession No. AF421355, NC017960, CP003504, and AOSM01000007), *ace* (GenBank accession No. AF159247 and KY613927), *gelE* (GenBank accession No D85393, KT598464, EU423275, and KY613931), and *asa1* (GenBank accession No. KT598461, KY613929, and U91527) gene sequences using OligoAnalyzer (Integrated DNA Technologies, USA). Primer specificity was confirmed by BLAST searches against the National Center for Biotechnology Information (NCBI) database (<https://www.ncbi.nlm.nih.gov/>). The eight pairs of primers and amplicon sizes are listed in [Table 1](#T1){ref-type="table"}.

###### Sequences of oligonucleotide primers used to detect putative virulence genes in *Enterococcus* isolates

![](jvs-20-e26-i001)

  Virulence gene   Gene description                            Primer           Sequence (5′ to 3′)               Amplicon size (bp)
  ---------------- ------------------------------------------- ---------------- --------------------------------- --------------------
  *fsr*            Regulator of *gelE* and *sprE* expression   Forward primer   CAA GGC ACT ATT TCT TAC TTA GG    1,016
  Reverse primer   AGC GCA TAA ATC AAC CAA G                                                                      
  *efm*            *E. faecium*-specific cell wall adhesin     Forward primer   GAA AAG TTG TCA GTC GTG G         818
  Reverse primer   TGT TTG TGA CAA ACC TTC ATG                                                                    
  *esp*            Enterococcal surface protein                Forward primer   CAT CTT TGA TTC TTG GTT GTC G     695
  Reverse primer   GTT ATA GGT ACG TAT GTT GCA TCA                                                                
  *cylA*           Hemolysin                                   Forward primer   GAG TTA GAT GAA TAT GGT CAT GGT   521
  Reverse primer   AGA AAC TAG CGA TGT AGG GTA ATA                                                                
  *cad1*           Pheromone cAD1 precursor lipoprotein        Forward primer   TTC CAA AAC TAC GCA CAA CA        423
  Reverse primer   CTT TTT CAG CAG CAT TCA CTA ATT                                                                
  *ace*            Collagen-binding cell wall protein          Forward primer   ATA GAA ACG GAT TTC GGA ACA G     298
  Reverse primer   TCA AAC TCG GCA AGT GAA ATA T                                                                  
  *gelE*           Gelatinase                                  Forward primer   TAT GAC AAT GCT TTT TGG GAT G     208
  Reverse primer   GCA CCC GAA ATA ATA TAA CCC                                                                    
  *asa1*           Aggregation substance                       Forward primer   AAC AAG CTT GGT CTG TGT ATC       168
  Reverse primer   TCT TCC CCT TTC TTG TTA TGA AC                                                                 

Multiplex PCR
-------------

PCR assays (20 µL) were conducted using PCR premix (iNtRON Biotechnology, Seongnam, Korea). Each reaction mixture contained 2 µL bacterial genomic DNA, 0.1 µM of each primer for *fsr*, *efm*, *esp*, *cylA*, *gelE*, and *asa1*, 0.16 µM of each primer for *cad1* and *ace*, 2.5 mM of each dNTP, 1.5 mM MgCl~2~, 10× reaction buffer, and 1 U Taq polymerase. The thermal cycler (Eppendorf, Hamburg, Germany) was programmed for initial denaturation at 94°C for 5 min, followed by 35 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, and then final elongation at 72°C for 7 min. PCR products were analyzed under UV light after separation by 1.5% agarose gel electrophoresis.

Determining the multiplex PCR detection limit
---------------------------------------------

The detection limit of multiplex PCR assays was determined by testing 5-fold serial dilutions of bacterial DNA of *E. faecalis* (field isolate) containing virulence genes *fsr*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1*. Similarly, the sensitivity for detecting the pheromone cAD1 precursor lipoprotein gene and *E. faecium*-specific cell wall adhesin gene was tested using *E. hirae* (field isolate) possessing the *cAD1* gene and *E. faecium* (field isolate) harboring *efm* and *cAD1* genes, respectively.

Sequencing method
-----------------

To confirm the exact virulence genes, all PCR products amplified by multiplex and simplex PCR were purified using a QIAquick Gel Extraction Kit (Qiagen) and sequencing was performed by Cosmogenetech Co. (Korea). Nucleotide sequences were analyzed by BLAST searching against the NCBI database.

Screening of virulence genes in *Enterococcus* spp.
---------------------------------------------------

Multiplex PCR was used to analyze eight virulence genes in 26 *E. faecalis*, 25 *E. faecium*, 20 *E. hirae*, and 9 *E. gallinarum* isolates from liver, femur and joint tissues of broiler chickens suffering lameness.

Antibiotic susceptibility testing
---------------------------------

The 16 antimicrobial minimal inhibitory concentrations (MICs) of *Enterococcus* isolates were determined using the Sensititre automated system (Trek Diagnostic Systems, USA) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2013). Ampicillin, chloramphenicol, ciprofloxacin, daptomycin, erythromycin, florfenicol, gentamicin, kanamycin, linezolid, quinupristin-dalfopristin, salinomycin, streptomycin, tetracycline, tigecycline, tylosin, and vancomycin antibiotics were tested with Sensititre plates. *E. faecalis* ATCC 29212 and *S. aureus* ATCC 25923 strains were used as quality controls.

RESULTS
=======

Development of multiplex PCR
----------------------------

Multiplex PCR assays were conducted using various concentrations of each primer pair to optimize the PCR conditions. Increasing the primer concentrations for *cad1* and *ace* genes facilitated the production of the expected PCR products at low DNA template concentrations. Multiplex PCR mixtures containing *efm* and *cAD1* genes in *E. faecium* genomic DNA generated 2 bands on 1.5% agarose gels: an 818 bp band for *efm* and a 423 bp band for *cad1* ([Fig. 1A](#F1){ref-type="fig"}, lane 1). Samples containing *fsr*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1* genes in *E. faecalis* genomic DNA yielded 7 bands: 1,016 bp for *fsr*, 695 bp for *esp*, 521 bp for *cylA*, 423 bp for *cad1*, 298 bp for *ace*, 208 bp for *gelE*, and 168 bp for *asa1* ([Fig. 1B](#F1){ref-type="fig"}, lane 10). Similarly, a multiplex PCR mixture containing only *E. hirae* genomic DNA amplified the *cad1* gene ([Fig. 1A](#F1){ref-type="fig"}, lane 19).

![Validation of eight primer pairs by simplex and multiplex PCR assays. To confirm that primer pairs correctly amplified their respective regions they were evaluated in simplex and multiplex PCR assays using (A) *E. faecium*, (B) *E. faecalis*, and (C) *E. hirae* genomic DNA isolated from broiler chickens suffering lameness. Lane M, 100 bp DNA markers; lane 1, multiplex PCR with *E. faecium* genomic DNA; lane 10, multiplex PCR with *E. faecalis* genomic DNA; lane 19, multiplex PCR with *E. hirae* genomic DNA; lanes 2, 11, and 20, simplex PCR with only *fsr* primers; lanes 3, 12, and 21, simplex PCR with only *efm* primers; lanes 4, 13, and 22, simplex PCR with only *esp* primers; lanes 5, 14, and 23, simplex PCR with only *cylA* primers; lanes 6, 15, and 24, simplex PCR with only *cad1* primers; lanes 7, 16, and 25, simplex PCR with only *ace* primers; lanes 8, 17, and 26, simplex PCR with only *gelE* primers; lanes 9, 18, and 27, simplex PCR with only *asa1* primers.\
PCR, polymerase chain reaction.](jvs-20-e26-g001){#F1}

Sequencing of PCR products
--------------------------

The eight amplicons were successfully amplified in eight single PCRs containing each gene-specific primer pair, as indicated by the expected PCR products on 1.5% agarose gels ([Fig. 1A](#F1){ref-type="fig"}, lanes 2--8; 1B, lanes 11--18; and 1C, lanes 20--27). All PCR products amplified in multiplex and single PCRs were confirmed by DNA sequencing, and sequence analysis showed that both multiplex and single PCR sequences were identical in the amplified regions (data not shown).

Detection limit of multiplex PCR
--------------------------------

To examine the detection limit of optimized multiplex PCR, genomic DNA from *E. faecium* (containing *efm* and *cAD1* genes), *E. faecalis* (containing *fsr*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1* genes), and *E. hirae* (containing the *cad1* gene) was prepared at DNA concentrations ranging from 12.8 pg to 200 ng. Multiplex PCR using the eight gene-specific primer pairs achieved detection limits of 64.0 pg/µL, 320.0 pg/µL, and 1.6 ng/µL DNA for *E. faecium*, *E. faecalis*, and *E. hirae*, respectively ([Fig. 2](#F2){ref-type="fig"}).

![Evaluation of multiplex PCR detection limits using genomic DNA from (A) *E. faecalis* (harboring *fsr*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1*), (B) *E. faecium* (harboring *efm* and *cad1*), and (C) *E. hirae* (harboring *cad1*). Lane M, 100 bp DNA markers; lane 1, 200.0 ng/µL DNA; lane 2, 40.0 ng/µL DNA; lane 3, 8.0 ng/µL DNA; lane 4, 1.6 ng/µL DNA; lane 5, 320.0 pg/µL DNA; lane 6, 64.0 pg/µL DNA; lane 7, 12.8 pg/µL DNA; lane 8, negative control.\
PCR, polymerase chain reaction.](jvs-20-e26-g002){#F2}

Screening of virulence genes in *Enterococcus* spp.
---------------------------------------------------

Optimized multiplex PCR was conducted to confirm the presence of the 8 virulence genes (*fsr*, *efm*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1*) in 80 *Enterococcus* strains isolated from clinical samples. Virulence gene profiles for *E. faecium*, *E. faecalis*, *E. hirae*, and *E. gallinarum* isolates are shown in [Table 2](#T2){ref-type="table"}. All 26 *E. faecium* isolates were positive for the *E. faecium*-specific cell wall adhesin gene *efm* and the pheromone cAD1 precursor lipoprotein gene cAD1. In contrast, the *fsr*, *esp*, *cylA*, *ace*, *gelE*, and *asa1* genes were not detected. Among the 25 *E. faecalis* isolates, positive results were obtained for 16 (64.0%) isolates for *fsr*, 1 (4.0%) for *esp*, 4 (16.0%) for *cylA*, 22 (88.0%) for *gelE*, and 11 (44.0%) for *asa1*. Additionally, *cAD1* and *ace* genes were positive in all *E. faecalis* isolates. Although all *E. hirae* isolates were positive for *cAD1*, no other virulence genes were found in *E. hirae* isolates. All 8 virulence factors were negative in 9 *E. gallinarum* isolates ([Table 2](#T2){ref-type="table"}). No significant difference in the prevalence of *fsr*, *efm*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, or *asa1* was observed between isolates from farms A or B.

###### Prevalence of virulence genes in 80 enterococcal isolates from liver, joint, and femur samples from commercial broiler chickens suffering lameness
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  Species                   Farm            Origin          Number of virulence genes (%)                                                                             
  ------------------------- --------------- --------------- ------------------------------- ----------- ----------- ------------ ------------ ----------- ----------- ---------
  *E. faecium* (n = 26)     A               Liver (n = 3)   0 (0.0)                         3 (100.0)   0 (0.0)     0 (0.0)      3 (100.0)    0 (0.0)     0 (0.0)     0 (0.0)
  Joint (n = 7)             0 (0.0)         7 (100.0)       0 (0.0)                         0 (0.0)     7 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  Femur (n = 5)             0 (0.0)         5 (100.0)       0 (0.0)                         0 (0.0)     5 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  B                         Liver (n = 3)   0 (0.0)         3 (100.0)                       0 (0.0)     0 (0.0)     3 (100.0)    0 (0.0)      0 (0.0)     0 (0.0)     
  Joint (n = 4)             0 (0.0)         4 (100.0)       0 (0.0)                         0 (0.0)     4 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  Femur (n = 4)             0 (0.0)         4 (100.0)       0 (0.0)                         0 (0.0)     4 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  Total                                     0 (0.0)         26 (100.0)                      0 (0.0)     0 (0.0)     26 (100.0)   0 (0.0)      0 (0.0)     0 (0.0)     
  *E. faecalis* (n = 25)    A               Liver (n = 1)   0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      1 (100.0)    1 (100.0)   1 (100.0)   0 (0.0)
  Joint (n = 6)             4 (66.7)        0 (0.0)         1 (16.7)                        2 (33.3)    6 (100.0)   6 (100.0)    6 (100.0)    3 (50.0)                
  Femur (n = 5)             4 (80.0)        0 (0.0)         0 (0.0)                         0 (0.0)     5 (100.0)   5 (100.0)    5 (100.0)    4 (80.0)                
  B                         Liver (n = 5)   2 (40.0)        0 (0.0)                         0 (0.0)     0 (0.0)     5 (100.0)    5 (100.0)    2 (40.0)    1 (20.0)    
  Joint (n = 6)             4 (66.7)        0 (0.0)         0 (0.0)                         2 (33.3)    6 (100.0)   6 (100.0)    6 (100.0)    3 (50.0)                
  Femur (n = 2)             2 (100.0)       0 (0.0)         0 (0.0)                         0 (0.0)     2 (100.0)   2 (100.0)    2 (100.0)    0 (0.0)                 
  Total                                     16 (64.0)       0 (0.0)                         1 (4.0)     4 (16.0)    25 (100.0)   25 (100.0)   22 (88.0)   11 (44.0)   
  *E. hirae* (n = 20)       A               Liver (n = 7)   0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      7 (100.0)    0 (0.0)     0 (0.0)     0 (0.0)
  Joint (n = 3)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     3 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  Femur (n = 8)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     8 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  B                         Liver (n = 0)   0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)     0 (0.0)     
  Joint (n = 2)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     2 (100.0)   0 (0.0)      0 (0.0)      0 (0.0)                 
  Femur (n = 0)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)                 
  Total                                     0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     20 (100.0)   0 (0.0)      0 (0.0)     0 (0.0)     
  *E. gallinarum* (n = 9)   A               Liver (n = 0)   0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)     0 (0.0)     0 (0.0)
  Joint (n = 3)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)                 
  Femur (n = 0)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)                 
  B                         Liver (n = 3)   0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)     0 (0.0)     
  Joint (n = 2)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)                 
  Femur (n = 1)             0 (0.0)         0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)                 
  Total                                     0 (0.0)         0 (0.0)                         0 (0.0)     0 (0.0)     0 (0.0)      0 (0.0)      0 (0.0)     0 (0.0)     

Antibiotic susceptibility
-------------------------

The MICs for 22 *E. faecium*, 22 *E. faecalis*, 3 *E. hirae*, and 2 *E. gallinarum* isolates were tested, and resistance breakpoints are presented in [Table 3](#T3){ref-type="table"}. All 49 isolates were resistant to tigecycline, while none were resistant to linezolid or vancomycin. Among the 16 antimicrobial agents tested, resistance to daptomycin (77.3% in *E. faecium* and 100% in *E. gallinarum*), erythromycin (50% in *E. faecalis* and 66.7% in *E. hirae*), ciprofloxacin (100% in *E. faecium*, 54.6% in *E. faecalis*, and 66.7% in *E. gallinarum*), quinupristin-dalfopristin (95.5% in *E. faecalis*), tetracycline (63.8% in *E. faecalis* and 100% in *E. gallinarum*), and tylosin (40.9% in *E. faecalis* and 66.7% in *E. hirae*) was most frequent among *Enterococcus* isolates. In addition, low levels of resistance to chloramphenicol, kanamycin, and streptomycin were observed. Multi-resistance patterns of isolates are shown in [Table 4](#T4){ref-type="table"}. All *Enterococcus* isolates were resistant to at least 2 different classes of antimicrobials, with 43 (87.8%) of 49 strains being resistant to 3 or more antimicrobials.

###### Distribution of antimicrobial MICs among 22 *E. faecium*, 22 *E. faecalis*, 3 *E. hirae*, and 2 *E. gallinarum* isolates from broiler chickens suffering lameness
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  CLSI subclass             Antimicrobials   Species        MIC~50~      MIC~90~    Resistance (%)   Total resistance (%)   Number of strains with MIC (µg/mL)^\*^                                                               
  ------------------------- ---------------- -------------- ------------ ---------- ---------------- ---------------------- ---------------------------------------- ---- ---- ---- ---- ---- ---- --- ---- ---- --- --- --- --- ---
  Penicillins               AMP              *E. faecium*   1            4          1 (4.6)          1 (2.0)                                                              18   1    2         1                                  
  *E. faecalis*             1                1              0 (0.0)                                  22                                                                                                                          
  *E. hirae*                1                2              0 (0.0)                                  2                      1                                                                                                    
  *E. gallinarum*           1                1              0 (0.0)                                  2                                                                                                                           
  Phenicols                 CHL              *E. faecium*   8            \> 32      3 (13.6)         7 (14.3)                                                                            18   1    3                             
  *E. faecalis*             8                \> 32          3 (13.6)                                                                                                      13   6    3                                            
  *E. hirae*                8                \> 32          1 (33.3)                                                                                                      2         1                                            
  *E. gallinarum*           8                8              0 (0.0)                                                                                                       2                                                      
  FFN                       *E. faecium*     4              \> 32        3 (13.6)   4 (8.2)                                                                                    18   1         3                                  
  *E. faecalis*             4                8              1 (4.6)                                                                                                  17   4         1                                            
  *E. hirae*                4                4              0 (0.0)                                                                                                  3                                                           
  *E. gallinarum*           4                4              0 (0.0)                                                                                                  2                                                           
  Lipopeptides              DAP^†^           *E. faecium*   8            16         17 (77.3)        21 (42.9)                                                                 1    4    14   2    1                             
  *E. faecalis*             2                4              1 (4.6)                                  2                      11                                       8    1                                                      
  *E. hirae*                2                8              1 (33.3)                                 1                      1                                             1                                                      
  *E. gallinarum*           8                8              2 (100)                                                                                                       2                                                      
  Macrolides                ERY              *E. faecium*   2            \> 64      5 (22.7)         18 (36.7)                                                            3    10   4                  5                         
  *E. faecalis*             2                \> 64          11 (50.0)                                8                      3                                                       1    10                                      
  *E. hirae*                32               \> 64          2 (66.7)                                 1                                                                              1    1                                       
  *E. gallinarum*           1                1              0 (0.0)                                  2                                                                                                                           
  Aminoglycosides           GEN              *E. faecium*   128          128        1 (4.6)          3 (6.1)                                                                                                20   1               1
  *E. faecalis*             128              128            1 (4.6)                                                                                                                           21                 1               
  *E. hirae*                128              1,024          1 (33.3)                                                                                                                          2             1                    
  *E. gallinarum*           128              128            0 (0.0)                                                                                                                           2                                  
  KAN                       *E. faecium*     128            1,024        3 (13.6)   10 (20.4)                                                                                                          15   4        1       2   
  *E. faecalis*             128              \> 2,048       6 (27.3)                                                                                                                          16                 1   5           
  *E. hirae*                128              \> 2,048       1 (33.3)                                                                                                                          2                      1           
  *E. gallinarum*           128              128            0 (0.0)                                                                                                                           2                                  
  STR                       *E. faecium*     128            128          2 (9.1)    11 (22.4)                                                                                                          20                1   1   
  *E. faecalis*             128              \> 2,048       8 (36.4)                                                                                                                          14                     8           
  *E. hirae*                128              \> 2,048       1 (33.3)                                                                                                                          2                      1           
  *E. gallinarum*           128              128            0 (0.0)                                                                                                                           2                                  
  Fluoroquinolone           CIP              *E. faecium*   4            \> 16      22 (100)         36 (73.5)                                                                      11   7    4                                  
  *E. faecalis*             4                \> 16          12 (54.6)                                                       10                                       2         10                                                
  *E. hirae*                16               \> 16          2 (66.7)                1                                                                                          2                                                 
  *E. gallinarum*           1                2              0 (0.0)                                  1                      1                                                                                                    
  Oxazolidinones            LZD              *E. faecium*   4            4          0 (0.0)          0 (0.0)                                                                   7    15                                           
  *E. faecalis*             2                4              0 (0.0)                                                         16                                       6                                                           
  *E. hirae*                2                4              0 (0.0)                                                         2                                        1                                                           
  *E. gallinarum*           4                4              0 (0.0)                                                                                                  2                                                           
  Streptogramins            SYN              *E. faecium*   2            4          5 (22.7)         27 (55.1)                                                            9    8    3    2                                       
  *E. faecalis*             8                16             21 (95.5)                                                       1                                        2    16   3                                                 
  *E. hirae*                2                4              1 (33.3)                                                        2                                        1                                                           
  *E. gallinarum*           2                2              0 (0.0)                                                         2                                                                                                    
  Glycylcyclines            TGC^‡^           *E. faecium*   1            4          22 (100.0)       49 (100.0)                                                      5    14   3                                                 
  *E. faecalis*             2                16             22 (100.0)              1                7                      14                                                                                                   
  *E. hirae*                0.5              4              3 (100.0)               2                1                                                                                                                           
  *E. gallinarum*           1                2              2 (100.0)                                2                                                                                                                           
  Tetracyclines             TET              *E. faecium*   2            \> 128     7 (31.8)         24 (49.0)                                                                 14   1              1   1    5                    
  *E. faecalis*             64               128            14 (63.8)                                                       8                                                       1    5    8                                  
  *E. hirae*                2                \> 128         1 (33.3)                                                        2                                                                 1                                  
  *E. gallinarum*           64               64             2 (100.0)                                                                                                                    2                                       
  TYLT                      *E. faecium*     4              \> 64        5 (22.7)   16 (32.7)                                                                             9    2    6              5                             
  *E. faecalis*             4                \> 64          9 (40.9)                                                        9                                        4                   9                                       
  *E. hirae*                64               \> 64          2 (66.7)                                                        1                                                            2                                       
  *E. gallinarum*           2                2              0 (0.0)                                                         2                                                                                                    
  Ionophore coccidiostats   SAL              *E. faecium*   2            4          1 (4.6)          1 (2.0)                                                                   19   1    1    1                                  
  *E. faecalis*             2                4              0 (0.0)                                                         19                                       3                                                           
  *E. hirae*                4                4              0 (0.0)                                                         1                                        2                                                           
  *E. gallinarum*           2                2              0 (0.0)                                                         2                                                                                                    
  Glycopeptides             VAN              *E. faecium*   2            2          0 (0.0)          0 (0.0)                                                                   21        1                                       
  *E. faecalis*             2                2              0 (0.0)                                                         22                                                                                                   
  *E. hirae*                2                2              0 (0.0)                                                         3                                                                                                    
  *E. gallinarum*           8                8              0 (0.0)                                                                                                       2                                                      

MIC, minimal inhibitory concentration; CLSI, Clinical and Laboratory Standards Institute; AMP, ampicillin; CHL, chloramphenicol; FFN, florfenicol; DAP, daptomycin; ERY, erythromycin; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; CIP, ciprofloxacin; LZD, linezolid; SYN, quinupristin/dalfopristin; TGC, tigecycline; TET, tetracycline; TYLT, tylosin; SAL, salinomycin; VAN, vancomycin.

^\*^Solid and dashed lines indicate the breakpoints of intermediate and complete resistance established by CLSI, respectively; ^†^The susceptibility breakpoint has only been established for daptomycin (≤ 4 µg/mL). In this study, isolates with an MIC ≥ 8 µg/mL were classified as resistant; ^‡^The susceptibility breakpoint has only been established for tigecycline (≤ 0.25 µg/mL). In this study, isolates with an MIC ≥ 0.5 µg/mL were classified as resistant.

###### Distribution of antimicrobial resistance patterns among 49 *Enterococcus* isolates from liver, joint, and femur samples from broilers suffering lameness

![](jvs-20-e26-i004)

  Resistance patterns                                    Number of strains with antimicrobial resistance   Total (%)                                            
  ------------------------------------------------------ ------------------------------------------------- ----------- --- --- ---- --- --- --- --- --- --- --- -----------
  TGC-CIP                                                2                                                             1                                        6 (12.2)
  TGC-SYN                                                                                                                  1   1                                6 (12.2)
  TGC-DAP                                                                                                                                       1               6 (12.2)
  TGC-CIP-DAP                                            2                                                 4           3                                        19 (38.8)
  TGC-CIP-KAN                                                                                              1                                                    19 (38.8)
  TGC-SYN-TET                                                                                                              1   2    2                           19 (38.8)
  TGC-SYN-CIP                                                                                                              2                                    19 (38.8)
  TGC-DAP-TET                                                                                                                                           1   1   19 (38.8)
  TGC-CIP-DAP-TET                                                                                                      2                                        7 (14.3)
  TGC-CIP-DAP-SYN                                                                                          1           1                                        7 (14.3)
  TGC-SYN-CIP-TET                                                                                                                   2                           7 (14.3)
  TGC-CIP-ERY-TYLT                                                                                                                              1               7 (14.3)
  TGC-SYN-TYLT-CIP-ERY                                                                                                              1                           2 (4.1)
  TGC-SYN-ERY-STR-TET                                                                                                          1                                2 (4.1)
  TGC-CIP-DAP-TET-SYN-ERY                                                                                  1                                                    3 (6.1)
  TGC-SYN-CIP-TYLT-ERY-DAP                                                                                                          1                           3 (6.1)
  TGC-SYN-CIP-TYLT-ERY-CHL                                                                                                          1                           3 (6.1)
  TGC-CIP-TET-SYN-ERY-TYLT-STR                                                                             1                   1                                6 (12.2)
  TGC-SYN-TYLT-ERY-STR-TET-KAN                                                                                                 2                                6 (12.2)
  TGC-CIP-STR-ERY-KAN-SYN-TET                                                                                                  1                                6 (12.2)
  TGC-CIP-STR-ERY-KAN-TYLT-CHL                                                                                                 1                                6 (12.2)
  TGC-CIP-DAP-TET-ERY-TYLT-CHL-FFN                                                                         1                                                    2 (4.1)
  TGC-SYN-CIP-TET-STR-ERY-TYLT-KAN                                                                                             1                                2 (4.1)
  TGC-CIP-DAP-TET-SYN-ERY-TYLT-CHL-FFN-SAL                                                                             1                                        2 (4.1)
  TGC-CIP-ERY-TYLT-SYN-STR-TET-CHL-KAN-GEN                                                                                                  1                   2 (4.1)
  TGC-SYN-CIP-TET-STR-ERY-TYLT-KAN-CHL-FFN-GEN                                                                             1                                    1 (2.0)
  TGC-CIP-DAP-TET-SYN-ERY-TYLT-STR-CHL-FFN-KAN-GEN-AMP   1                                                                                                      1 (2.0)
  Total                                                  5                                                 9           8   5   10   7   0   1   2   0   1   1   49

TGC, tigecycline; CIP, ciprofloxacin; SYN, quinupristin/dalfopristin; DAP, daptomycin; KAN, kanamycin; TET, tetracycline; ERY, erythromycin; TYLT, tylosin; STR, streptomycin; CHL, chloramphenicol; FFN, florfenicol; SAL, salinomycin; GEN, gentamicin; AMP, ampicillin.

DISCUSSION
==========

Many *Enterococcus* spp. from various sources including humans, animals, birds, and the environment are generally considered harmless, although some can become opportunistic pathogens by acquiring antibiotic resistance and putative virulence genes from other bacteria through horizontal gene transfer \[[@B10]-[@B15]\]. Herein, the pathogenicity of isolates was evaluated by screening for the presence of virulence factors, and a multiplex PCR method was developed for the simultaneous detection of 8 enterococcal virulence genes (*fsr*, *efm*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1*). All primer pairs were validated using simplex PCR before being employed in multiplex PCR and only 1 amplified product of the expected size was observed in each simplex PCR as expected. In addition, we confirmed that each primer pair amplified the correct putative virulence gene by DNA sequencing.

To evaluate the sensitivity of multiplex PCR, DNA isolated from *E. faecium* harboring *efm* and *cAD1* genes, *E. faecalis* harboring *fsr*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1* genes, and *E. hirae* harboring the *cad1* gene was tested at different concentrations. The detection limits of *E. faecium*, *E. faecalis*, and *E. hirae* were 64.0 pg/µL, 320.0 pg/µL, and 1.6 ng/µL DNA, respectively. Moreover, multiplex PCR was carried out using 5 µL heat-treated suspensions from individual colonies as DNA template, and the sensitivity results mirrored the detection limits obtained using genomic DNA isolated with a DNA extraction kit (data not shown). Thus, the multiplex PCR method for the 8 virulence genes was shown to be a reliable and rapid alternative for phenotypic testing and simplex PCR.

Furthermore, the multiplex PCR method was applied to screen 26 *E. faecium*, 25 *E. faecalis*, 20 *E. hirae*, and 9 *E. gallinarum* isolates from broiler chickens suffering lameness for the presence of these virulence genes, and the results showed that the assay could detect all 8 virulence genes in *Enterococcus* spp. isolates. Additionally, all 26 *E. faecium* isolates were positive for *efm*, whereas all *E. faecalis* isolates were positive for ace. Among the virulence genes analyzed, the sex pheromone cAD1 precursor lipoprotein gene *cad1*, which is related to the secretion of signaling molecules for intercellular communication, was detected in all 26 *E. faecium*, 25 *E. faecalis*, and 20 *E. hirae* isolates. Interestingly, aggregation substances encoded by sex pheromone plasmids are known to mediate aggregation between bacterial cells and facilitate transfer of plasmids \[[@B16]\]. Hemolysin secreted by bacteria damages cell membranes and facilitates the infection process \[[@B16],[@B17]\].

The distribution of *asa1* and *cylA* among *E. faecalis* isolates was 44% and 16%, respectively. The *gelE* gene is believed to enhance the survivability of *Enterococcus spp*. in extra-intestinal environments, and this gene was found in 88% of the 25 *E. faecalis* isolates. Gelatinase activity is known to be co-controlled by *gelE* and *fsr* genes, and lack of *fsr* affects the production of gelatinase \[[@B18],[@B19]\]. The *fsr* gene product, which hydrolyzes gelatin, casein, hemoglobin, and other bioactive peptides, was detected in 64% of *E. faecalis* isolates. Among *E. faecalis* isolates harboring the *esp* gene, which contributes to enterococcal biofilm formation, resistance to environmental stresses, and adhesion to eukaryotic cells, only 1 of 25 isolates was positive fpr *esp*. Meanwhile, *fsr*, *esp*, *cylA*, *ace*, *gelE*, and *asa1* genes were not detected in 26 *E. faecium* isolates, and *fsr*, *esp*, *cylA*, *cad1*, *ace*, *gelE*, and *asa1* genes were detected in 2 of 25 *E. faecalis* isolates. No virulence factors were found in any of the 9 *E. gallinarum* isolates.

*Enterococcus* spp. are widespread, resistant to various antimicrobial agents, and have the ability to rapidly acquire resistance to various antimicrobial agents \[[@B5],[@B20]\]. Herein, all 49 *Enterococcus* isolates were resistant to tigecycline, followed by ciprofloxacin (73.5%), quinupristin/dalfopristin (55.1%), tetracycline (49.0%), daptomycin (42.9%), erythromycin (36.7%), and tylosin (32.7%). Resistance to linezolid and vancomycin was not observed in any of the *E. faecium*, *E. faecalis*, *E. hirae*, or *E. gallinarum* isolates. Among the 49 *Enterococcus* isolates, 22 *E. faecium* isolates were resistant to ciprofloxacin (100.0%) and daptomycin (77.3%).

Moreover, *E. faecalis* displayed 95.5%, 63.8%, 54.6%, and 50.0% resistance to high levels of quinupristin/dalfopristin, tetracycline, ciprofloxacin, and erythromycin, respectively. Additionally, 66.7% of *E. hirae* isolates were resistant to tylosin, ciprofloxacin, and erythromycin. Resistance to daptomycin, tetracycline, and tigecycline was 100% in all *E. gallinarum* isolates.

Comparison of antimicrobial agents revealed that the frequency of resistance to daptomycin and ciprofloxacin was much higher in *E. faecium* (77.3% and 100.0%, respectively) than in *E. faecalis* (4.6% and 54.6%, respectively). Similarly, resistance to erythromycin, streptomycin, quinupristin/dalfopristin, and tetracycline was higher in *E. faecalis* (50.0%, 36.4%, 95.5%, and 63.8%, respectively) than *E. faecium* (22.7%, 9.1%, 22.7%, and 31.8%, respectively). Multidrug resistance was observed in the majority of isolates, and the prevalence of multidrug resistance (resistant to at least 3 antimicrobials) was 19/22 (86.4%) for *E. faecium*, 20/22 (90.9%) for *E. faecalis*, 2/3 (66.7%) for *E. hirae*, and 2/2 (100.0%) for *E. gallinarum*.

To the best of our knowledge, this report is the first to provide detailed antibiotic resistance patterns for *Enterococcus* spp. isolated from commercial broiler chickens suffering lameness. The developed multiplex PCR method may have diagnostic value for the reliable, cost- and time-effective detection of 8 putative virulence genes in *Enterococcus* spp. simultaneously using a single assay.
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